TRCT
SRTS icon

Tower Research Capital (TRC)’s Sensus Healthcare SRTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470 Sell
118
-614
-84% -$2.73K ﹤0.01% 4863
2025
Q4 		$2.91K Sell
732
-228
-24% -$845 ﹤0.01% 4454
2025
Q3 		$3.01K Buy
960
+859
+850% +$3.37K ﹤0.01% 4554
2025
Q2 		$479 Sell
101
-186
-65% -$871 ﹤0.01% 5012
2025
Q1 		$1.36K Sell
287
-1,391
-83% -$8.1K ﹤0.01% 4726
2024
Q4 		$11.6K Buy
1,678
+546
+48% +$4K ﹤0.01% 3692
2024
Q3 		$6.57K Sell
1,132
-1,654
-59% -$10K ﹤0.01% 4131
2024
Q2 		$14.8K Sell
2,786
-704
-20% -$3.24K ﹤0.01% 3932
2024
Q1 		$13.3K Sell
3,490
-3,455
-50% -$12.5K ﹤0.01% 3410
2023
Q4 		$16.4K Buy
6,945
+66
+1% +$155 ﹤0.01% 3782
2023
Q3 		$19.1K Buy
6,879
+4,740
+222% +$14.5K ﹤0.01% 3421
2023
Q2 		$6.74K Sell
2,139
-1,666
-44% -$6.02K ﹤0.01% 4666
2023
Q1 		$20K Sell
3,805
-2,382
-39% -$17.1K ﹤0.01% 3448
2022
Q4 		$46K Sell
6,187
-5,165
-45% -$46.6K ﹤0.01% 2419
2022
Q3 		$142K Buy
11,352
+6,668
+142% +$79.7K ﹤0.01% 2244
2022
Q2 		$36K Buy
4,684
+4,149
+776% +$34.8K ﹤0.01% 3194
2022
Q1 		$5K Sell
535
-944
-64% -$8.62K ﹤0.01% 5098
2021
Q4 		$11K Sell
1,479
-3,277
-69% -$17.9K ﹤0.01% 4454
2021
Q3 		$17K Buy
4,756
+3,133
+193% +$11.5K ﹤0.01% 3880
2021
Q2 		$6K Sell
1,623
-5,077
-76% -$19K ﹤0.01% 4642
2021
Q1 		$26K Buy
+6,700
New +$27.5K ﹤0.01% 3688
2020
Q4 		– Sell
-1,603
Closed -$4K – 5394
2020
Q3 		$4K Buy
1,603
+1,602
+160,200% +$4.51K ﹤0.01% 4440
2020
Q2 		$0 Sell
1
-2,510
-100% -$6.54K ﹤0.01% 4980
2020
Q1 		$6K Sell
2,511
-4,864
-66% -$18.1K ﹤0.01% 2251
2019
Q4 		$26K Buy
7,375
+5,023
+214% +$22.7K ﹤0.01% 1762
2019
Q3 		$15K Buy
2,352
+1,982
+536% +$11.5K ﹤0.01% 2676
2019
Q2 		$2K Sell
370
-131
-26% -$768 ﹤0.01% 3314
2019
Q1 		$4K Buy
+501
New +$3.87K ﹤0.01% 3197
2018
Q4 		– Sell
-13
Closed – – 4322
2018
Q3 		$0 Buy
+13
New +$94 ﹤0.01% 4218
2017
Q2 		– Sell
-200
Closed -$1K – 3403
2017
Q1 		$1K Sell
200
-800
-80% -$3.77K ﹤0.01% 2847
2016
Q4 		$5K Buy
1,000
+260
+35% +$1.52K ﹤0.01% 3066
2016
Q3 		$5K Buy
+740
New +$4.63K ﹤0.01% 2575

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM

Tower Research Capital (TRC)'s SRTS Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Sensus Healthcare (SRTS) stake by 84% in Q1 2026, selling an estimated $2.73K and leaving 118 shares worth $470. The position accounts for ﹤0.01% of the portfolio, ranked #4863.

Tower Research Capital (TRC) first reported a position in SRTS in Q3 2016 and has held it in 32 quarters since. The position peaked at $142K in Q3 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Tower Research Capital (TRC) held 118 shares of Sensus Healthcare worth $470 as of Q1 2026.
  • Tower Research Capital (TRC) sold 614 Sensus Healthcare shares in Q1 2026, an estimated $2.73K.
  • Sensus Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4863 holding.
  • Tower Research Capital (TRC) first reported a position in Sensus Healthcare in Q3 2016 and has held it in 32 quarters since.
  • Tower Research Capital (TRC)'s Sensus Healthcare position peaked at $142K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.